Sphingosine 1-phosphate receptor 1 governs endothelial barrier function and angiogenesis by upregulating endoglin signaling
暂无分享,去创建一个
S. Bellusci | Chengshui Chen | Jin-San Zhang | Nian Dong | K. Dai | Junjie Chen | Beibei Wang | Y. Fang | Yuting Lin | Dengmin Wu | Ya Fang
[1] T. Hla,et al. Endothelial sphingosine 1-phosphate receptors promote vascular normalization and antitumor therapy , 2020, Proceedings of the National Academy of Sciences.
[2] S. Butz,et al. Interference With ESAM (Endothelial Cell-Selective Adhesion Molecule) Plus Vascular Endothelial-Cadherin Causes Immediate Lethality and Lung-Specific Blood Coagulation , 2019, Arteriosclerosis, thrombosis, and vascular biology.
[3] T. Hla,et al. Sphingosine 1-phosphate: Lipid signaling in pathology and therapy , 2019, Science.
[4] T. Hla,et al. Sphingosine 1-phosphate receptor 1 regulates cell-surface localization of membrane proteins in endothelial cells. , 2019, Biochimica et biophysica acta. General subjects.
[5] S. Swendeman,et al. Sphingosine 1‐Phosphate Receptor 1 Signaling Maintains Endothelial Cell Barrier Function and Protects Against Immune Complex–Induced Vascular Injury , 2018, Arthritis & rheumatology.
[6] H. Arthur,et al. Soluble endoglin regulates expression of angiogenesis-related proteins and induction of arteriovenous malformations in a mouse model of hereditary hemorrhagic telangiectasia , 2018, Disease Models & Mechanisms.
[7] Agnès Desroches-Castan,et al. BMP9, but not BMP10, acts as a quiescence factor on tumor growth, vessel normalization and metastasis in a mouse model of breast cancer , 2018, Journal of Experimental & Clinical Cancer Research.
[8] B. Larrivée,et al. BMP9 (Bone Morphogenetic Protein-9)/Alk1 (Activin-Like Kinase Receptor Type I) Signaling Prevents Hyperglycemia-Induced Vascular Permeability , 2018, Arteriosclerosis, thrombosis, and vascular biology.
[9] R. Pastori,et al. Intra‐Amniotic Soluble Endoglin Impairs Lung Development in Neonatal Rats , 2017, American journal of respiratory cell and molecular biology.
[10] C. Betsholtz,et al. Endoglin prevents vascular malformation by regulating flow-induced cell migration and specification through VEGFR2 signalling , 2017, Nature Cell Biology.
[11] C. Iadecola,et al. Size-selective opening of the blood–brain barrier by targeting endothelial sphingosine 1–phosphate receptor 1 , 2017, Proceedings of the National Academy of Sciences.
[12] P. D’Amore,et al. Disorders of Vascular Permeability. , 2016, Annual review of pathology.
[13] Lloyd H. Michael,et al. The Guide for the Care and Use of Laboratory Animals. , 2016, ILAR journal.
[14] K. Brown,et al. Selective deletion of the endothelial sphingosine-1-phosphate 1 receptor exacerbates kidney ischemia-reperfusion injury , 2013, Kidney international.
[15] John Greenwood,et al. LRG1 promotes angiogenesis by modulating endothelial TGFß signalling , 2013, Nature.
[16] R. Stevens,et al. Sphingosine-1-phosphate and its receptors: structure, signaling, and influence. , 2013, Annual review of biochemistry.
[17] M. Goumans,et al. Deficiency for endoglin in tumor vasculature weakens the endothelial barrier to metastatic dissemination , 2013, The Journal of experimental medicine.
[18] W. Zhong,et al. Endoglin Requirement for BMP9 Signaling in Endothelial Cells Reveals New Mechanism of Action for Selective Anti-Endoglin Antibodies , 2012, PloS one.
[19] R. Hersperger,et al. A potent and selective S1P(1) antagonist with efficacy in experimental autoimmune encephalomyelitis. , 2012, Chemistry & biology.
[20] S. Rafii,et al. Flow-regulated endothelial S1P receptor-1 signaling sustains vascular development. , 2012, Developmental cell.
[21] C. Betsholtz,et al. The sphingosine-1-phosphate receptor S1PR1 restricts sprouting angiogenesis by regulating the interplay between VE-cadherin and VEGFR2. , 2012, Developmental cell.
[22] T. Zimmers,et al. BMP9 and BMP10 are critical for postnatal retinal vascular remodeling. , 2012, Blood.
[23] Laure Gambardella,et al. A Computational Tool for Quantitative Analysis of Vascular Networks , 2011, PloS one.
[24] T. Hla,et al. Regulation of mammalian physiology, development, and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors. , 2011, Chemical reviews.
[25] T. Hla,et al. Engagement of S1P₁-degradative mechanisms leads to vascular leak in mice. , 2011, The Journal of clinical investigation.
[26] R. Adams,et al. Inducible gene targeting in the neonatal vasculature and analysis of retinal angiogenesis in mice , 2010, Nature Protocols.
[27] Rachael J. Oakenfull,et al. Pathogenesis of Arteriovenous Malformations in the Absence of Endoglin , 2010, Circulation research.
[28] S. Coughlin,et al. Sphingosine-1-phosphate in the plasma compartment regulates basal and inflammation-induced vascular leak in mice. , 2009, The Journal of clinical investigation.
[29] Elisabetta Dejana,et al. The control of vascular integrity by endothelial cell junctions: molecular basis and pathological implications. , 2009, Developmental cell.
[30] G. Blobe,et al. Endoglin Promotes Transforming Growth Factor β-mediated Smad 1/5/8 Signaling and Inhibits Endothelial Cell Migration through Its Association with GIPC* , 2008, Journal of Biological Chemistry.
[31] Ian Parker,et al. Enhancement of capillary leakage and restoration of lymphocyte egress by a chiral S1P1 antagonist in vivo , 2006, Nature chemical biology.
[32] A. Parrill,et al. S1P1-selective in vivo-active agonists from high-throughput screening: off-the-shelf chemical probes of receptor interactions, signaling, and fate. , 2005, Chemistry & biology.
[33] M. Goumans,et al. Endoglin promotes endothelial cell proliferation and TGF‐β/ALK1 signal transduction , 2004, The EMBO journal.
[34] R. Proia,et al. G-protein-coupled receptor S1P1 acts within endothelial cells to regulate vascular maturation. , 2003, Blood.
[35] Michael D. Davis,et al. The Immune Modulator FTY720 Targets Sphingosine 1-Phosphate Receptors* , 2002, The Journal of Biological Chemistry.
[36] J. P. Hobson,et al. Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. , 2000, The Journal of clinical investigation.
[37] P. Carmeliet. Mechanisms of angiogenesis and arteriogenesis , 2000, Nature Medicine.
[38] D. Dumont,et al. A murine model of hereditary hemorrhagic telangiectasia. , 1999, The Journal of clinical investigation.
[39] B. Brooke,et al. Defective angiogenesis in mice lacking endoglin. , 1999, Science.
[40] D. W. Johnson,et al. Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1 , 1994, Nature Genetics.